These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Recurrent cerebral venous thrombosis associated with heterozygote methylenetetrahydrofolate reductase C677T mutation and sickle cell trait without homocysteinemia: an autopsy case report and review of literature. Ali Z, Troncoso JC, Fowler DR. Forensic Sci Int; 2014 Sep; 242():e52-e55. PubMed ID: 25074331 [Abstract] [Full Text] [Related]
25. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Morelli VM, Lourenço DM, D'Almeida V, Franco RF, Miranda F, Zago MA, Noguti MA, Cruz E, Kerbauy J. Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942 [Abstract] [Full Text] [Related]
29. Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion. Kim NK, Choi YK, Kang MS, Choi DH, Cha SH, An MO, Lee S, Jeung M, Ko JJ, Oh D. Thromb Res; 2006 Apr; 117(6):653-8. PubMed ID: 15985285 [Abstract] [Full Text] [Related]
37. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study. Naess IA, Christiansen SC, Romundstad PR, Cannegieter SC, Blom HJ, Rosendaal FR, Hammerstrøm J. Br J Haematol; 2008 May; 141(4):529-35. PubMed ID: 18318759 [Abstract] [Full Text] [Related]